Government Changes Rules to Make Doing Business Easier for Pharma and Food Companies

Date:

Share post:

In a major step toward trust-based governance, the Government of India has operationalised key reforms under the Jan VishwasAct, 2026. The initiative rationalises minor offences under the Drugs and Cosmetics Act, 1940, and the Food Safety and Standards Act, 2006, significantly reducing the compliance burden for businesses while protecting public health.

The landmark reforms decriminalise minor, technical, and procedural violations such as basic record-keeping gaps or minor cosmetic labelling errors,replacing criminal proceedings with administrative penalties. Notably, Section 29 of the Drugs and Cosmetics Act has been completely omitted. For food safety, duplicate provisions regarding obstructing officers have been removed to align with the Bharatiya Nyaya Sanhita (BNS). To ensure smooth implementation, the government has introduced dedicated Adjudicating Authorities and a transparent appeal mechanism.

Crucially, the Ministry of Health and Family Welfare emphasized that strict criminal laws remain firmly in place for serious offences involving spurious or adulterated products that risk consumer safety. This balanced approach slashes unnecessary legal hurdles for compliant businesses, fostering a modern, transparent, and highly efficient regulatory ecosystem in India’s food and pharma sectors.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...